By Dr. Shweta Agarwal, MBBS, DGO Medically reviewed by Dr. Shweta Agarwal, MBBS, DGO Last updated: June 2026
Information on this page is educational and does not replace a medical consultation. Outcomes depend on individual clinical factors.
Aansh Hospital & IVF Center is a government-registered Level-2 ART clinic (Reg. No. MH/AC/2024/15441/L2/Chandrapur/132), part of a growing chain of fertility centers across Vidarbha and northern Telangana, with our headquarters and in-house embryology lab in Chandrapur. Our government ART registration covers the full range of regulated ART services under the clinical leadership of Dr. Shweta Agarwal and embryology led by Aayush Agarwal, Ph.D..
If you are reading this after getting a negative beta-hCG result, or after a cycle that ended earlier than expected, I want to start with something that is often not said plainly enough: what you are feeling right now is appropriate. A failed IVF cycle is not a minor setback. It is a loss — of a very specific hope, of a great deal of physical and emotional effort, and often of a very detailed imagined future. Grief, anger, numbness, exhaustion, and the particular cruelty of not knowing why — all of these are normal responses to an abnormal situation.
This guide does two things. First, it tries to give the grief the space it deserves — because minimising it does not help and can leave you worse-equipped to make decisions later. Second, it turns to the clinical: what a proper review after a failed cycle looks like, what can be learned from the data your cycle generated, and how the approach can be adjusted. Those two halves are not in tension. Processing what happened emotionally and understanding it clinically are both part of moving forward.
What does it actually feel like after a failed IVF cycle — and is my reaction normal?
Yes. Whatever you are feeling, it is unlikely to be an overreaction.
The emotional weight of a failed IVF cycle is often underestimated by people who have not been through it. The cycle itself involves weeks of injections, daily monitoring appointments, the physical demands of stimulation and retrieval, the particular anxiety of the two-week wait — and all of it is oriented toward a single moment that then goes the wrong way. The hope that builds over the course of a cycle makes the fall proportionally steep.
Common feelings after a negative result include profound sadness, a sense of failure (even when there is nothing you did wrong), anger — at circumstances, at your own body, at how unfair it is — and a kind of disorientation, because you had been living toward a particular outcome and now that future is suspended. Many people describe a specific exhaustion that is different from ordinary tiredness: the tiredness of having wanted something very much and not getting it.
Relationship strain is also common and worth acknowledging directly. Partners often process grief differently — one person may want to talk about it constantly; the other may need quiet. Neither response is wrong. The asymmetry can feel isolating when both people are already depleted. If you and your partner find yourselves struggling to be in the same emotional place after a result, that is not a sign something is wrong with your relationship — it is a sign you are both in pain and processing it differently.
It is also completely valid to not feel ready to think about what comes next immediately. Taking days or weeks before re-engaging with clinical decisions is not giving up. It is self-preservation, and it is a reasonable thing to do.
Does a failed cycle mean IVF will not work for me?
No. A negative result from a single IVF cycle does not determine what is possible in subsequent cycles — but it does generate information that should be used.
The word "failed" in clinical contexts is a loaded one. What actually happened in a cycle that did not result in a pregnancy could be any number of things: the embryo may not have implanted for reasons related to embryo quality, endometrial receptivity, timing, or factors that were not visible in the data. Not all of these are addressable; many are. The important distinction is that a single negative result is a data point, not a verdict.
What changes between cycles — and what should change — is not simply "try again." It is "try again differently, based on what this cycle showed us." A cycle that retrieved fewer eggs than expected suggests a stimulation protocol review. A cycle in which embryos fertilised but did not develop to blastocyst points toward something in the embryology picture. A cycle with good-quality embryos that did not implant raises questions about endometrial factors. Each of these paths leads somewhere different. The review matters.
That said: some couples do pursue multiple cycles before a result, and some do not achieve a result at all. We cannot promise that adjusting the approach will produce a different outcome — only that a careful, individualised review gives you the best possible basis for the next decision, whatever that turns out to be.
What does a proper post-cycle clinical review examine?
A thorough review after a failed IVF cycle looks at every stage of the cycle in sequence, treating the data your cycle generated as a diagnostic resource. Bringing your full cycle records — stimulation protocol, monitoring scan results, embryology report, and transfer notes — to any review appointment is essential, whether that is at Aansh or at another clinic.
Here is what a careful review examines:
Ovarian stimulation response and protocol. How did your ovaries respond to the stimulation medications? The number of follicles that developed, how they responded to the trigger, and the timing of retrieval are all relevant. Under-response (few follicles despite adequate stimulation) may suggest that the protocol dose or medication type needs adjustment, or that ovarian reserve was lower than anticipated. If you had PCOS, a different stimulation approach may reduce the risk of ovarian hyperstimulation syndrome (OHSS) while still achieving adequate egg numbers. Your AMH and AFC results together with your actual response help your clinician classify whether the response was as expected, lower, or higher than anticipated.
Number and maturity of eggs retrieved. How many eggs were collected? How many were mature (MII oocytes) and available for fertilisation? A large number of retrieved eggs is not always better than a moderate number; what matters most is the number of mature, competent eggs. Very low numbers after a reasonable stimulation suggest either a protocol change or further investigation of ovarian reserve (AMH, antral follicle count).
Fertilisation method and result. Were the eggs fertilised using standard IVF (insemination in a dish) or ICSI (injection of a single sperm)? What was the fertilisation rate? Very low fertilisation rates — particularly with standard IVF — may indicate the need to switch to ICSI in a future cycle. Elevated DNA fragmentation in sperm (assessed via a separate DNA fragmentation test, not a standard semen analysis) can sometimes explain unexpected fertilisation or early development problems even when the basic semen analysis appeared adequate.
Embryo development to blastocyst. How many embryos developed, and how far did they develop? Embryos that arrest early (stopping development at Day 2–3 without progressing) may reflect egg quality, sperm quality, or laboratory factors. Embryos that reach Day 3 (cleavage stage) but do not progress to blastocyst by Day 5 are also informative. Blastocyst culture — allowing embryos to develop to Day 5 before transfer — provides more information about embryo quality and selects the embryos most likely to implant. If blastocyst culture was not used in the previous cycle, it may be worth discussing.
Embryo quality at transfer. What grade were the transferred embryos? Grading systems vary between laboratories, but the morphological quality of the embryo at transfer — expansion, inner cell mass, trophectoderm — is associated with implantation potential. Very low-grade embryos have a lower probability of implanting; if all embryos in a cycle are low-grade, this points toward upstream factors (stimulation, egg quality, or embryology laboratory conditions).
Endometrial and uterine factors. Was the endometrium (uterine lining) at an adequate thickness at the time of transfer? Was its appearance (triple-line pattern on ultrasound) appropriate? The endometrium needs to be in a receptive state for implantation to occur. If there were concerns about the lining in the previous cycle — thin lining, poor response to oestrogen, or an irregular pattern — these warrant specific investigation. A uterine cavity assessment (sonohysterography or hysteroscopy) can check for structural issues such as polyps, fibroids, or adhesions that may have been missed previously.
Transfer details. Was the transfer technically straightforward? A difficult transfer — where the catheter encountered resistance or was repositioned — can occasionally affect outcome, though its contribution is modest. If there were specific technical difficulties, these may point toward the value of a mock transfer procedure to map the cervical canal in advance.
Whether PGT-A would be appropriate. Preimplantation genetic testing for aneuploidies (PGT-A) screens embryos for chromosomal abnormalities before transfer. It is not a universal recommendation — it requires sufficient embryos to biopsy, adds cost, and does not improve outcomes in all patient groups — but in specific situations (recurrent implantation failure, advanced maternal age, repeated poor embryo development) it can provide information that meaningfully changes the decision about which embryo to transfer.
Male partner investigation. Has a DNA fragmentation test been performed on the sperm sample? Semen analysis measures count, motility, and morphology — but does not assess DNA integrity. In couples where embryos fertilised but did not develop well, or where there have been multiple failed cycles with otherwise unexplained embryo quality issues, sperm DNA fragmentation testing adds important information.
How might the next approach be adjusted?
The value of a thorough review is that it moves you from "trying the same thing again" to "trying something different, based on what we learned." What changes depends entirely on what the review found — there is no single adjustment that applies to all failed cycles.
Common adjustments include:
- A different stimulation protocol or dose, particularly if the response was unexpectedly low or high
- Switching from standard IVF fertilisation to ICSI, or adding ICSI for some eggs
- Adding sperm DNA fragmentation testing and, if elevated, exploring ways to improve sperm quality or use testicular sperm
- Extending embryo culture to blastocyst stage if Day 3 transfers were used previously
- A uterine cavity investigation (hysteroscopy) before the next fresh or frozen cycle if endometrial concerns were present
- Adding endometrial receptivity assessment (ERA) or other endometrial investigations in cases of repeated implantation failure — though the evidence base for these tests continues to evolve and their use should be discussed in the context of your specific situation
- A frozen embryo transfer (FET) using embryos cryopreserved from the current cycle, rather than a fresh cycle
- Consideration of PGT-A if the review findings and your situation meet the criteria discussed above
Not all of these are applicable or appropriate for every couple. The review exists to identify which adjustments are relevant for you specifically.
What is the value of a frozen embryo transfer — and does it count as a new cycle?
If your cycle produced embryos that were frozen (cryopreserved) rather than transferred — or if you had supernumerary embryos that were frozen after the fresh transfer — a frozen embryo transfer (FET) cycle offers a meaningful opportunity that is lower in physical intensity than a full stimulation cycle.
In a frozen embryo transfer, the ovaries are not re-stimulated. The preparation involves endometrial preparation (typically oestrogen and then progesterone supplementation) to bring the lining to an appropriate state for transfer. The embryo that was frozen is then thawed and transferred. The physical burden is significantly less than a full IVF cycle — no injections for stimulation, no egg retrieval under anaesthesia — and the recovery from the preparation phase is correspondingly lighter.
Whether a FET or a new full stimulation cycle is the right next step depends on whether you have frozen embryos available, the quality of those embryos, and what the review found. If the frozen embryos are of good morphological quality, a FET is generally the first logical step before embarking on a new retrieval cycle. If no embryos were frozen, or if the frozen embryos are poor quality or chromosomally abnormal (if PGT-A was done), a new stimulation cycle may be the appropriate path.
A failed fresh cycle followed by a FET using frozen embryos from the same stimulation is a single retrieval cycle used most efficiently — not a series of failures, but a planned protocol.
What about a second opinion after a failed IVF cycle?
A second opinion after a failed cycle is not a sign of disloyalty to your current team — it is a clinically sensible step, and a good fertility team will support it rather than resist it.
What a second opinion adds is an independent review of your cycle records: the stimulation data, embryology report, transfer notes, and any investigation results. A clinician who was not involved in the original cycle sometimes identifies something that was not foregrounded — a protocol adjustment that was not tried, an investigation that was not completed, a pattern in the embryology data that points toward a specific cause.
The most useful second opinion is not a generalised reassurance but a structured review of your records. To make it as useful as possible, bring: the stimulation monitoring charts, the embryology grading report, the transfer report, the beta-hCG results, and any semen analysis or investigation reports from both partners.
Aansh offers a free second-opinion review for couples who have completed at least one IVF cycle elsewhere and want an independent assessment before deciding on next steps. You can call us on +91 80056 85160 or reach us via WhatsApp.
How do we cope while deciding what comes next?
There is no formula for this. What works varies considerably between people and between couples. A few things that tend to help:
Give the grief its due. Trying to skip past the emotional impact to get to the clinical decisions quickly usually does not work — and often means the emotional weight resurfaces later, at a more disruptive moment. Taking time to grieve is not wasting time.
Manage the information environment. The period immediately after a negative result is not a good time to research IVF statistics, read forum threads, or compare your cycle to other people's cycles. The data out there is not personalised to your situation, and it will not tell you what your review will tell you. Give yourself some distance from the information before re-engaging with the research.
Communicate with your partner, even when it is hard. As noted earlier, partners often process grief at different speeds and in different ways. A brief, honest acknowledgement of the asymmetry — "I know we're both hurting but in different ways right now" — is often more useful than trying to synchronise your grief.
Consider professional support. Many couples find fertility counselling genuinely helpful, not as a last resort, but as a resource during the cycle and after a negative result. IVF अपयश (a failed IVF cycle) carries a weight that friends and family — however well-meaning — often cannot fully meet, because they have not experienced it. A counsellor who works specifically with fertility patients can provide a different kind of support. Ask your clinic whether a fertility counsellor referral is available.
Set a timeline for re-engagement, if that helps you. Some people find it useful to say: "We will take three weeks before we look at this again." Having a defined pause gives permission to not be making decisions right now, without leaving the future entirely open-ended.
Contact the clinic if you need to talk through what happened. The follow-up review appointment is the primary place for clinical discussion — but if you have questions that feel urgent before then, or if you are struggling and want to speak with someone on the team, please do call. We would rather you reach out than not. +91 80056 85160 or WhatsApp.
When is the right time to re-engage with treatment planning?
There is no correct answer that applies to everyone. Physically, most women are ready for the next step within four to six weeks of a negative result — the body recovers from stimulation relatively quickly, and a natural menstrual cycle or two is all that is typically needed before the next protocol can begin. Emotionally, the timeline is different and more individual.
The follow-up review appointment — typically one to two weeks after the beta-hCG result — is a good first step, even if you are not ready to make a decision at that point. It is an opportunity to understand what the cycle data shows, ask questions, and get the clinical picture clear. That information can then sit with you for as long as you need before you decide how or whether to proceed.
There is no deadline. A few weeks of processing does not meaningfully change the clinical outlook in most situations. If ovarian reserve is a specific concern — something your team will have discussed with you — the timeline question is worth raising explicitly, because reserve does change over time. But this should be a conversation with your clinician based on your investigation results, not a reason to rush a decision before you are ready.
Take your time. When you are ready, we are here.